News & Perspective

Mar 23, 2018

Mar 23, 2018

ASP Scan (Weekly) for Mar 23, 2018

Contact precautions and resistance
Antimicrobial use on farms
CARB-X funds antibiotic candidate
Resistance surveillance in poor nations
MDR-TB treatment outcomes
New stewardship e-book
Sepsis, diagnostics technology
Resistant TB in Europe
Appropriate C diff testing
Fast sepsis detection

Nov 09, 2012

Nov 09, 2012

BioCryst may drop quest for US approval of peramivir

(CIDRAP News) – BioCryst Pharmaceuticals Inc. signaled yesterday it will probably give up on seeking a US license for the influenza drug peramivir, a move that would reduce the already limited options for severely ill flu patients in need of an intravenous antiviral drug.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»